Recurrent breast cancer

Studies devoted to survival analysis in men with breast carcinoma are significantly smaller than similar studies in women. In most cases, only the general survival rate is evaluated. The majority of authors agree that the prognosis in men with breast cancer is significantly worse than in women with similar disease (Dymarsky 1980; Guinee et al. 1993). The lower general survival rate in men results from an older age and later stages of the disease at the time of the diagnosis. According to the literature, the 5-year survival rate in men with breast carcinoma ranges from 36 to 66 % (Korde et al. 2010). The 10-year survival rates in patients with stage I-Ia is 91.5 %, IIb is 72.5 %, III is 44.2 %, and IV does not exceed 3.2 % (Guinee et al. 1993; Letyagin 2006). © Springer International Publishing Switzerland 2015.